Search
Bimatoprost grenod
go.drugbank.com/drugs/DB21634ExperimentalBimatoprost grenod is a small molecule drug. Bimatoprost grenod has a monoisotopic molecular weight of 574.33 Da.
Irucalantide
go.drugbank.com/drugs/DB21654ExperimentalIrucalantide is a small molecule drug. Irucalantide has a monoisotopic molecular weight of 1682.72 Da.
Setidegrasib
go.drugbank.com/drugs/DB21670InvestigationalSetidegrasib is a small molecule drug. The usage of the INN stem '-rasib' in the name indicates that Setidegrasib is a Ras protein inhibitor. … Setidegrasib has a monoisotopic molecular weight of 1116.48 Da.
Icotrokinra
go.drugbank.com/drugs/DB21724ApprovedInvestigationalIcotrokinra is a first-in-class, targeted oral peptide and interleukin-23 (IL-23) receptor antagonist. … [L56108,L56118] Icotrokinra was approved by the US FDA in March 2026 for the systemic treatment of moderate-to-severe plaque psoriasis.[L56108]
Vormatrigine
go.drugbank.com/drugs/DB21731InvestigationalVormatrigine is a small molecule drug. The usage of the INN stem '-trigine' in the name indicates that Vormatrigine is a sodium channel blocker, signal transduction modulator. … Vormatrigine has a monoisotopic molecular weight of 406.09 Da.
Abenacianine
go.drugbank.com/drugs/DB21734InvestigationalAbenacianine is a small molecule drug. Abenacianine has a monoisotopic molecular weight of 2448.87 Da.
Iscartrelvir
go.drugbank.com/drugs/DB21737ExperimentalIscartrelvir is a small molecule drug. The usage of the INN stem '-trelvir' in the name indicates that Iscartrelvir is a antiviral 3CL protease inhibitor. … Iscartrelvir has a monoisotopic molecular weight of 525.1 Da.
Talogreptide mesaroxetan
go.drugbank.com/drugs/DB21743ExperimentalTalogreptide mesaroxetan is a small molecule drug. The usage of the INN stem '-xetan' in the name indicates that Talogreptide mesaroxetan is a chelating agent. … Talogreptide mesaroxetan has a monoisotopic molecular weight of 1769.07 Da.
Vezocolmitide
go.drugbank.com/drugs/DB21751InvestigationalVezocolmitide is under investigation in clinical trial NCT06178679 (Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease
Synonyms: ST-100XT-150
go.drugbank.com/drugs/DB21756InvestigationalXT-150 is a locally injectable non-viral therapy expressing IL-10v, a proprietary modified variant of IL-10.[L52125] It is being developed by Xalud Therapeutics.